Cerebral Venous Thrombosis: A Tunisian Monocenter Study on 160 Patients
- PMID: 27582021
- DOI: 10.1177/1076029616665168
Cerebral Venous Thrombosis: A Tunisian Monocenter Study on 160 Patients
Abstract
Objective: Data regarding cerebral venous thrombosis in North Africa are scarce. This study aims to identify the clinical features, risk factors, outcome, and prognosis of cerebral venous thrombosis in Tunisia.
Methods: Data of 160 patients with radiologically confirmed cerebral venous thrombosis, hospitalized in Mongi Ben Hmida National Institute of Neurology (Tunis, Tunisia), were retrospectively collected and analyzed.
Results: The mean age was 37.3 years with a female predominance (83.1%). The mode of onset was subacute in most cases (56.2%). Headache was the most common symptom (71.3%), and focal neurologic symptoms were the main clinical presentation (41.8%). The most common sites of thrombosis were the superior sagittal sinus (65%) and the lateral sinus (60.6%). More than 1 sinus was involved in 114 (71.2%) patients. Parenchymal lesions observed in 85 (53.1%) patients did not correlate with cerebral venous thrombosis extent. Major risk factors were obstetric causes (pregnancy and puerperium) found in 46 (38.6% of women aged <50 years) patients, followed by anemia (28.1%) and congenital or acquired thrombophilia (16.2%). Mortality rate was of 6.6%. Good outcome at 6 months (modified Rankin Scale ≤2) was observed in 105 (87.5%)of 120 patients available for follow-up. Predictors of poor outcome were altered consciousness and elevated plasma C-reactive protein levels.
Conclusion: Clinical and radiologic presentation of cerebral venous thrombosis in Tunisia was quite similar to other parts of the world with, however, a particularly high frequency of obstetric causes. Plasma C-reactive protein level should be considered as a prognostic factor in CVT.
Keywords: cerebral venous thrombosis; clinical thrombophilia; vascular disease.
Similar articles
-
Cerebral venous thrombosis: clinical features, risk factors, and long-term outcome in a Tunisian cohort.J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1291-5. doi: 10.1016/j.jstrokecerebrovasdis.2013.10.025. Epub 2014 Jan 22. J Stroke Cerebrovasc Dis. 2014. PMID: 24462460
-
Cerebral venous thrombosis: influence of risk factors and imaging findings on prognosis.Clin Neurol Neurosurg. 2005 Aug;107(5):371-8. doi: 10.1016/j.clineuro.2004.10.004. Epub 2004 Nov 18. Clin Neurol Neurosurg. 2005. PMID: 16023530
-
A Multicenter Study of 1144 Patients with Cerebral Venous Thrombosis: The VENOST Study.J Stroke Cerebrovasc Dis. 2017 Aug;26(8):1848-1857. doi: 10.1016/j.jstrokecerebrovasdis.2017.04.020. Epub 2017 Jun 2. J Stroke Cerebrovasc Dis. 2017. PMID: 28583818
-
Cerebral venous thrombosis: continental disparities.Neurol Sci. 2017 Nov;38(11):1963-1968. doi: 10.1007/s10072-017-3082-7. Epub 2017 Aug 14. Neurol Sci. 2017. PMID: 28808795 Review.
-
Intracranial venous thrombosis in the parturient.Anesthesiology. 2007 Oct;107(4):652-8; quiz 687-8. doi: 10.1097/01.anes.0000282103.70955.c4. Anesthesiology. 2007. PMID: 17893462 Review.
Cited by
-
SARS-CoV-2 and Stroke Characteristics: A Report From the Multinational COVID-19 Stroke Study Group.Stroke. 2021 May;52(5):e117-e130. doi: 10.1161/STROKEAHA.120.032927. Epub 2021 Apr 21. Stroke. 2021. PMID: 33878892 Free PMC article.
-
Cerebral Venous Thrombosis.Fed Pract. 2017 Jul;34(7):33-37. Fed Pract. 2017. PMID: 30766287 Free PMC article.
-
Clinical, radiological profile and prognostic role of transcranial color-coded duplex in cerebral venous thrombosis: a case-control study.BMC Neurol. 2023 Aug 7;23(1):295. doi: 10.1186/s12883-023-03342-z. BMC Neurol. 2023. PMID: 37550633 Free PMC article.
-
Association of neutrophil to lymphocyte ratio and D-dimer with functional outcome in patients with cerebral venous sinus thrombosis.BMC Neurol. 2023 Jan 19;23(1):30. doi: 10.1186/s12883-022-03030-4. BMC Neurol. 2023. PMID: 36658518 Free PMC article.
-
Key prognostic risk factors linked to poor functional outcomes in cerebral venous sinus thrombosis: a systematic review and meta-analysis.BMC Neurol. 2025 Feb 6;25(1):52. doi: 10.1186/s12883-025-04059-x. BMC Neurol. 2025. PMID: 39915720 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials